Abstract
Biological protein-based entities that form nanostructures ranging from 8 to 50 nm in size represent promising candidates in the development of novel immunotherapeutics against cancer and microbial pathogens. These recombinant nanoparticles usually consist of major coat or core proteins derived from viruses like for instance papillomavirus, polyomavirus, parvovirus or hepatitis B virus that spontaneously assemble into these highly ordered, supramolecular, icosahedral structures. By genetic engineering of permissive sites or cross-linking to surface-exposed subunit domains these nanoparticles successfully serve as carrier matrix with per se adjuvant activity for the delivery of appropriate guest peptides, protein fragments and complete proteins. Using this nanobiotechnology, potent humoral and cell-mediated immunity with emphasis on CD4 and CD8 T cell responses are induced against self or non-self foreign antigens representing appropriate immunostimulatory epitopes or complete proteins of microbial pathogens or tumor-associated antigens. Breaking of T and B cell tolerance required for therapeutic interventions against cancer represents the hallmark of such an outstanding antigen delivery system. In combination with the increasing identification of validated target antigens from pathogens or tumors, and promising progress in bioprocess development, such nanostructures offer novel homologous or heterologous treatment and prevention opportunities against a variety of malignant and infectious diseases.
Keywords: Virus-like-particles, Antigen delivery, Vaccines, Infectious diseases, Cancer and Nanobiotechnology
Current Nanoscience
Title: Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention
Volume: 2 Issue: 4
Author(s): Christoph Reichel, Marc Brinkman, Claus Ruehland, Christian O. A. Reiser and Juergen Hess
Affiliation:
Keywords: Virus-like-particles, Antigen delivery, Vaccines, Infectious diseases, Cancer and Nanobiotechnology
Abstract: Biological protein-based entities that form nanostructures ranging from 8 to 50 nm in size represent promising candidates in the development of novel immunotherapeutics against cancer and microbial pathogens. These recombinant nanoparticles usually consist of major coat or core proteins derived from viruses like for instance papillomavirus, polyomavirus, parvovirus or hepatitis B virus that spontaneously assemble into these highly ordered, supramolecular, icosahedral structures. By genetic engineering of permissive sites or cross-linking to surface-exposed subunit domains these nanoparticles successfully serve as carrier matrix with per se adjuvant activity for the delivery of appropriate guest peptides, protein fragments and complete proteins. Using this nanobiotechnology, potent humoral and cell-mediated immunity with emphasis on CD4 and CD8 T cell responses are induced against self or non-self foreign antigens representing appropriate immunostimulatory epitopes or complete proteins of microbial pathogens or tumor-associated antigens. Breaking of T and B cell tolerance required for therapeutic interventions against cancer represents the hallmark of such an outstanding antigen delivery system. In combination with the increasing identification of validated target antigens from pathogens or tumors, and promising progress in bioprocess development, such nanostructures offer novel homologous or heterologous treatment and prevention opportunities against a variety of malignant and infectious diseases.
Export Options
About this article
Cite this article as:
Reichel Christoph, Brinkman Marc, Ruehland Claus, A. Reiser O. Christian and Hess Juergen, Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention, Current Nanoscience 2006; 2 (4) . https://dx.doi.org/10.2174/157341306778699338
DOI https://dx.doi.org/10.2174/157341306778699338 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radiology of Oropharyngeal Cancer - Institutional Experience and Literature Review -
Current Cancer Therapy Reviews Management of Vulvar Cancer
Reviews on Recent Clinical Trials Pre-therapy Iodine-131 Uptake Value as a Prediction Method for Metastatic Lymph Node Status in Patients with Differentiated Thyroid Carcinoma
Current Medical Imaging Anticancer Evaluation of Novel Quinazolinone Acetamides: Synthesis and Characterization
Anti-Cancer Agents in Medicinal Chemistry Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Current Cancer Drug Targets The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research From TGF-β to Cancer Therapy
Current Drug Targets Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Advances in Nano Drugs for Cancer Chemotherapy
Current Cancer Drug Targets Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery Drug Delivery Systems for Photodynamic Therapy
Recent Patents on Drug Delivery & Formulation EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Current Medicinal Chemistry Beta-glucans is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects
Current Pharmaceutical Biotechnology Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Current Cancer Drug Targets Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Current Medicinal Chemistry Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry Recent Developments in the Applications of Palladium Complexes Bearing N-Heterocyclic Carbene Ligands
Current Organic Chemistry The Balancing Act between Colonisers and Inflammation: T regulatory and TH17 Cells in Mucosal Immunity during Otitis Media
Current Immunology Reviews (Discontinued) Identification of Flavonoids by LC-MS/MS in Leaves Extract From <i>Protium heptaphyllum</i> (Aubl.) March and Antioxidant Activity in Mice
The Natural Products Journal